🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Targeted Intervention on Sleep Disorders During Tobacco or Cannabis Cessation Therapy

RecruitingNAAges 18 Years - anyAllCentre Hospitalier St Anne
NCT07202351 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

During a cessation therapy for tobacco or cannabis, sleep disorders are one of the main risk factors of relapse, and a symptom of substance withdrawing. In this study, we make the hypothesis that identifying and managing potential sleep disorders during cessation treatment may contribute to maintain tobacco / cannabis abstinence on the long-term. To evaluate the impact of such intervention, we will conduct a randomised pilot study among patients consulting at two addiction prevention and care centres, for smoking or cannabis use cessation treatment. Control group will benefit of usual care (a multidisciplinary care with individual and group therapies); intervention group will benefit in addition of a systematic screening of sleep disorders, and in case of a diagnosed alteration, they will be addressed to the Chronos centre, for specific care to help them manage and reduce the consequence

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * patients over 18 years old * presenting at the participating addiction treatment centres for a smoking or cabannis use cessation therapy * who agree to participate to the study * affiliated to the French health insurance system Exclusion Criteria: * Patients hospitalised during the cessation therapy * Patients undergoing sleep disorders treatment * Patients participating to another study * Patients with psychotic disorders (according the DSM-5 classification) * Patients who do not want the additionnal intervention and care if randomised in the intervention group
💊

What it tests

  • Screening and management of sleep disorders
📍

Where

1 site
GHU Paris Psychiatrie et Neurosciences
Paris, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy